Physician

Himabindu Ramasahaya Reddy, MD

According to 2025 Medicare claims, Himabindu Reddy, MD (NPI: 1780658708) practices rheumatology in the Fort Worth-Arlington-Grapevine, TX market, with the plurality of this provider's patient population coming from Tarrant, TX. This provider's primary affiliated billing organization is LONE STAR ARTHRITIS AND RHEUMATOLOGY ASSOCIATES PLLC (NPI: 1255119582; TIN: 933370554) and primary practice location at 76109-3562. Reddy is affiliated with the WellMed Texas Medicare ACO, LLC (ACO ID: A4889) and UT Southwestern Accountable Care Network (ACO ID: D0211), participating under both the MSSP and REACH models.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 480 traditional Medicare patients, billed 100,745 HCPCS/CPT codes, and received $1,924,847 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 4,995 prescription claims across 735 beneficiaries totaling $3,116,980 in drug costs, led by Enbrel Sureclick (Etanercept). 2016 DME data shows 12 claims. Open Payments data shows 168 records totaling $49,771. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $980,167 to $1,924,847. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,942,646 and ending at $3,116,980. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$962K$1.9M2015 Medicare payment: $980,167 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $984,015 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,397,842 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,268,007 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,264,973 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,213,353 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,022,323 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $427,015 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $240,941 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,924,847 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201552859,265$980,167
201655054,644$984,015
201760398,542$1,397,842
201857390,628$1,268,007
201957382,628$1,264,973
202054979,855$1,213,353
202150865,232$1,022,323
202244418,757$427,015
202347113,984$240,941
2024480100,745$1,924,847

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.9M$3.8M2015 Drug cost: $1,942,646 (USD; Tot_Drug_Cst)2016 Drug cost: $2,130,038 (USD; Tot_Drug_Cst)2017 Drug cost: $3,256,977 (USD; Tot_Drug_Cst)2018 Drug cost: $3,137,242 (USD; Tot_Drug_Cst)2019 Drug cost: $3,791,328 (USD; Tot_Drug_Cst)2020 Drug cost: $3,556,776 (USD; Tot_Drug_Cst)2021 Drug cost: $2,775,412 (USD; Tot_Drug_Cst)2022 Drug cost: $3,515,235 (USD; Tot_Drug_Cst)2023 Drug cost: $3,694,597 (USD; Tot_Drug_Cst)2024 Drug cost: $3,116,980 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156836,855$1,942,646
20167006,800$2,130,038
20178498,405$3,256,977
20188818,411$3,137,242
20199198,404$3,791,328
20208788,140$3,556,776
20218547,516$2,775,412
20228107,177$3,515,235
20237936,780$3,694,597
20247354,995$3,116,980

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$478$9562016 Medicare payment: $956 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R12$956
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more120120$112
96413Administration of chemotherapy into vein, 1 hour or less70446$99
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4311,442$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8392$67
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's361760$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept1022,856$797,972
Humira(Cf) PenAdalimumab922,576$626,670
EnbrelEtanercept451,344$363,398
Cosentyx Sensoready (2 Pens)Secukinumab25700$182,203
Xeljanz XrTofacitinib Citrate25750$152,161

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.164$9,421GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.4$40,350Eli Lilly and Company
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Himabindu Ramasahaya Reddy, MD?

Tedicare shows public-source Medicare data for Himabindu Ramasahaya Reddy, MD (NPI 1780658708), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Himabindu Ramasahaya Reddy, MD have ACO affiliation data?

Himabindu Ramasahaya Reddy, MD is shown with ACO affiliation data for WellMed Texas Medicare ACO, LLC (MSSP, ACO ID A4889) and UT Southwestern Accountable Care Network (REACH, ACO ID D0211).

What billing organization is linked to Himabindu Ramasahaya Reddy, MD?

Himabindu Ramasahaya Reddy, MD is linked to LONE STAR ARTHRITIS AND RHEUMATOLOGY ASSOCIATES PLLC (billing NPI 1255119582) in the available physician profile data.

Does Himabindu Ramasahaya Reddy, MD have Open Payments data?

Himabindu Ramasahaya Reddy, MD has 168 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.